Accessories:

Instruction for use, pipette

Principle of Test:

Immunochromatographic assay

Product Performance:

Cut-off Level: 1000ng/ml

INTENDED USE:

The One-step Amphetamine Test is a lateral flow, one-step immunoassay for the qualitative detection of amphetamine in human urine at a cut-off of 1000ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use.The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible in the result window. The line in the test region (T) is the test line and the line in the control region (C) is the control line which is used to indicate proper performance of the device. No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the amphetamine in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:

Instruction for use

Principle of Test:

Immunochromatographic assay

Product Performance:

Cut-off Level: 1000ng/ml

INTENDED USE: The One-step Amphetamine Test is a lateral flow, one-step immunoassay for the qualitative detection of amphetamine in human urine at a cut-off of 1000ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use.The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1.Bring the pouched test strip to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test strip from the sealed pouch.
3. Immerse the test strip in the urine specimen with the arrow end pointing toward the urine. Do not immerse the strip above the printed MAX line.
4. After a minimum of 15 seconds, remove the test strip from the urine and lay flat on a non-absorptive clean surface. Alternatively , leave the test strip in the urine specimen as long as the strip is not immersed above the MAX line.
5. Read results between 3-8 minutes. Do not read results after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible, one in the test region (T) and another one in the control region (C). No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the amphetamine in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:

Instruction for use, pipette

Principle of Test:

Immunochromatographic assay

Product Performance:

Cut-off Level: 300ng/ml

INTENDED USE:

The One-Step BAR Test is a lateral flow, one-step immunoassay for the qualitative detection of barbiturates, primarily secobarbital, in human urine at a cut-off of 300ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use.The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST
MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,
AMP-1000ng/ml,BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml, TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1. Bring the pouched test device to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test device from the sealed pouch. Label the device with patient name or control number. Lay it on a flat, clean and dry surface.
3. Hold the dropper vertically and transfer 3 full drops of urine to the sample well (S) of the test device, and then start the timer. Use a separate pipette and device for each specimen or control.
4. Read result between 3 to 8 minutes. Do not read result after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible in the result window. The line in the test region (T) is the test line and the line in the control region (C) is the control line which is used to indicate proper performance of the device. No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the barbiturates in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:

Instruction for use

Principle of Test:

Immunochromatographic assay

Product Performance:

Cut-off Level: 300ng/ml

INTENDED USE: 

The One-Step BAR Test is a lateral flow, one-step immunoassay for the qualitative detection of barbiturates, primarily secobarbital, in human urine at a cut-off of 300ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use.The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST
MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml,BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1.Bring the pouched test strip to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test strip from the sealed pouch.
3. Immerse the test strip in the urine specimen with the arrow end pointing toward the urine. Do not immerse the strip above the printed MAX line.
4. After a minimum of 15 seconds, remove the test strip from the urine and lay flat on a non-absorptive clean surface. Alternatively , leave the test strip in the urine specimen as long as the strip is not immersed above the MAX line.
5. Read results between 3-8 minutes. Do not read results after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible, one in the test region (T) and another one in the control region (C). No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the barbiturates in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:

Instruction for use, pipette

Principle of Test:

Immunochromatographic assay

Product Performance:

Cut-off Level: 10 ng/ml

INTENDED USE:

The One-Step BUP Test is a lateral flow, one-step immunoassay for the qualitative detection of buprenorphine in human urine at a cut-off concentration of 10ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use. The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1. Bring the pouched test device to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test device from the sealed pouch. Label the device with patient name or control number. Lay it on a flat, clean and dry surface.
3. Hold the dropper vertically and transfer 3 full drops of urine to the sample well (S) of the test device, and then start the timer. Use a separate pipette and device for each specimen or control.
4. Read result between 3 to 8 minutes. Do not read result after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible in the result window. The line in the test region (T) is the test line and the line in the control region (C) is the control line which is used to indicate proper performance of the device. No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the buprenorphine in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:

Instruction for use

Principle of Test:

Immunochromatographic assay

Product Performance:

Cut-off Level: 10 ng/ml

INTENDED USE:

The One-Step BUP Test is a lateral flow, one-step immunoassay for the qualitative detection of buprenorphine in human urine at cut-off concentration of 10ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use. The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1.Bring the pouched test strip to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test strip from the sealed pouch.
3. Immerse the test strip in the urine specimen with the arrow end pointing toward the urine. Do not immerse the strip above the printed MAX line.
4. After a minimum of 15 seconds, remove the test strip from the urine and lay flat on a non-absorptive clean surface. Alternatively , leave the test strip in the urine specimen as long as the strip is not immersed above the MAX line.
5. Read results between 3-8 minutes. Do not read results after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible, one in the test region (T) and another one in the control region (C). No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the buprenorphine in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:

Instruction for use, pipette

Principle of Test:

Immunochromatographic assay

Product Performance:

Cut-off Level: 300 ng/ml

INTENDED USE:

The One-Step Benzodiazepine Test is a lateral flow, one-step immunoassay for the qualitative detection of benzodiazepines in human urine at a cut-off of 300ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use. The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1. Bring the pouched test device to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test device from the sealed pouch. Label the device with patient name or control number. Lay it on a flat, clean and dry surface.
3. Hold the dropper vertically and transfer 3 full drops of urine to the sample well (S) of the test device, and then start the timer. Use a separate pipette and device for each specimen or control.
4. Read result between 3 to 8 minutes. Do not read result after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible in the result window. The line in the test region (T) is the test line and the line in the control region (C) is the control line which is used to indicate proper performance of the device. No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the benzodiazepines in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

    Accessories:
Instruction for use
    Principle of Test:
Immunochromatographic assay
    Product Performance:
Cut-off Level: 300 ng/ml

INTENDED USE: The One-Step Benzodiazepine Test is a lateral flow, one-step immunoassay for the qualitative detection of benzodiazepines in human urine at a cut-off of 300ng/ml. This product is used to obtain a visual，qualitative result and is intended for professional use. The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1.Bring the pouched test strip to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test strip from the sealed pouch.
3. Immerse the test strip in the urine specimen with the arrow end pointing toward the urine. Do not immerse the strip above the printed MAX line.
4. After a minimum of 15 seconds, remove the test strip from the urine and lay flat on a non-absorptive clean surface. Alternatively , leave the test strip in the urine specimen as long as the strip is not immersed above the MAX line.
5. Read results between 3-8 minutes. Do not read results after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible, one in the test region (T) and another one in the control region (C). No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the benzodiazepines in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:
Instruction for use, pipette
Principle of Test:
Immunochromatographic assay
Product Performance:
Cut-off Level: 300 ng/ml

INTENDED USE: The One-Step Cocaine Test is a lateral flow, one-step immunoassay for the qualitative detection of benzoylecgonine (cocaine metabolite) in human urine at a cut-off of 300ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use. The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1. Bring the pouched test device to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test device from the sealed pouch. Label the device with patient name or control number. Lay it on a flat, clean and dry surface.
3. Hold the dropper vertically and transfer 3 full drops of urine to the sample well (S) of the test device, and then start the timer. Use a separate pipette and device for each specimen or control.
4. Read result between 3 to 8 minutes. Do not read result after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible in the result window. The line in the test region (T) is the test line and the line in the control region (C) is the control line which is used to indicate proper performance of the device. No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the cocaine in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:
Instruction for use, pipette
Principle of Test:
Immunochromatographic assay
Product Performance:
Cut-off Level: 300 ng/ml

INTENDED USE: The One-Step Cocaine Test is a lateral flow, one-step immunoassay for the qualitative detection of benzoylecgonine (cocaine metabolite) in human urine at a cut-off of 300ng/ml. This product is used to obtain a visual, qualitative result and is intended for professional use. The assay should not be used without proper supervision and is not intended for over the counter sale to lay persons.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1.Bring the pouched test strip to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test strip from the sealed pouch.
3. Immerse the test strip in the urine specimen with the arrow end pointing toward the urine. Do not immerse the strip above the printed MAX line.
4. After a minimum of 15 seconds, remove the test strip from the urine and lay flat on a non-absorptive clean surface. Alternatively , leave the test strip in the urine specimen as long as the strip is not immersed above the MAX line.
5. Read results between 3-8 minutes. Do not read results after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible, one in the test region (T) and another one in the control region (C). No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the cocaine in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

Accessories:
Instruction for use, pipette
Principle of Test:
Immunochromatographic assay
Product Performance:
Cut-off Level: 1000 ng/ml

INTENDED USE: One-Step Ketamine Test is a one step, lateral flow chromatographic immunoassay for the qualitative detection of Ketamine and its metabolites in human urine. The test cut off is 1000ng/ml.

SENSITIVITY OF THE TEST

MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,

AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,

TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1. Bring the pouched test device to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test device from the sealed pouch. Label the device with patient name or control number. Lay it on a flat, clean and dry surface.
3. Hold the dropper vertically and transfer 3 full drops of urine to the sample well (S) of the test device, and then start the timer. Use a separate pipette and device for each specimen or control.
4. Read result between 3 to 8 minutes. Do not read result after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible in the result window. The line in the test region (T) is the test line and the line in the control region (C) is the control line which is used to indicate proper performance of the device. No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the ketamine in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.

    Accessories:
Instruction for use
    Principle of Test:
Immunochromatographic assay
    Product Performance:
Cut-off Level: 1000 ng/ml

INTENDED USE: One-Step Ketamine Test is a one step, lateral flow chromatographic immunoassay for the qualitative detection of Ketamine and its metabolites in human urine. The test cut off is 1000ng/ml.

SENSITIVITY OF THE TEST
MOP-300ng/ml, MET-1000ng/ml, KET-1000ng/ml, MDMA-500ng/ml, COC-300ng/ml, THC-50ng/ml,
AMP-1000ng/ml, BAR-300ng/ml, BZO-300ng/ml, MTD-300ng/ml, PCP-25ng/ml, BUP-10ng/ml,
TCA-1000ng/ml, OXY-100ng/ml, PPX-300ng/ml, OPI-2000ng/ml.

TEST PROCEDURE
1.Bring the pouched test strip to room temperature (15-30℃) prior to testing. Do not open the pouch until ready to perform the assay.
2. Remove the test strip from the sealed pouch.
3. Immerse the test strip in the urine specimen with the arrow end pointing toward the urine. Do not immerse the strip above the printed MAX line.
4. After a minimum of 15 seconds, remove the test strip from the urine and lay flat on a non-absorptive clean surface. Alternatively , leave the test strip in the urine specimen as long as the strip is not immersed above the MAX line.
5. Read results between 3-8 minutes. Do not read results after 10 minutes.

INTERPRETATION OF RESULTS

Negative: Two red lines are visible, one in the test region (T) and another one in the control region (C). No matter the color intensity of the test line is weaker or stronger than that of the control line, the test result is negative.

Positive: Only one red line visible in the control region (C) and the absence of the test line indicates a positive result.

NOTICE: A very faint line in the test region indicates that the ketamine in the specimen is near the cut-off level of the test. These specimens should be retested or confirmed with a more specific method before a positive determination is made.

Invalid: The test is invalid if the control line is not visible regardless of the presence or absence of the test line.

NOTICE: Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for the control line failure. Review the procedure and repeat the test with a new device. If problem persists, please contact your local distributor.